| The Japanese clinical practice guidelines for management of sepsis and septic shock 2020 (J-SSCG 2020) M Egi, H Ogura, T Yatabe, K Atagi, S Inoue, T Iba, Y Kakihana, ... Journal of intensive care 9, 1-144, 2021 | 170 | 2021 |
| Glomerulosclerosis induced by deficiency of membrane-associated guanylate kinase inverted 2 in kidney podocytes N Shirata, K Ihara, K Yamamoto-Nonaka, T Seki, S Makino, JAO Trejo, ... Journal of the American Society of Nephrology 28 (9), 2654-2669, 2017 | 41 | 2017 |
| Low-dose atrial natriuretic peptide for prevention or treatment of acute kidney injury: a systematic review and meta-analysis H Yamada, K Doi, T Tsukamoto, H Kiyomoto, K Yamashita, M Yanagita, ... Critical Care 23, 1-13, 2019 | 39 | 2019 |
| Intestinal bacterial translocation contributes to diabetic kidney disease HT Linh, Y Iwata, Y Senda, Y Sakai-Takemori, Y Nakade, M Oshima, ... Journal of the American Society of Nephrology 33 (6), 1105-1119, 2022 | 37 | 2022 |
| Acetaminophen administration and the risk of acute kidney injury: a self-controlled case series study S Hiragi, H Yamada, T Tsukamoto, K Yoshida, N Kondo, T Matsubara, ... Clinical Epidemiology, 265-276, 2018 | 34 | 2018 |
| The Japanese Society for Apheresis clinical practice guideline for therapeutic apheresis T Abe, H Matsuo, R Abe, S Abe, H Asada, A Ashida, A Baba, K Eguchi, ... Therapeutic Apheresis and Dialysis 25 (6), 728-876, 2021 | 30 | 2021 |
| Peritoneal dialysis for COVID-19-associated acute kidney injury M Nagatomo, H Yamada, K Shinozuka, M Shimoto, T Yunoki, S Ohtsuru Critical care 24, 1-3, 2020 | 22 | 2020 |
| MAGI-2 orchestrates the localization of backbone proteins in the slit diaphragm of podocytes H Yamada, N Shirata, S Makino, T Miyake, JAO Trejo, ... Kidney International 99 (2), 382-395, 2021 | 21 | 2021 |
| Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (September 2021) K Yamakawa, R Yamamoto, T Terayama, H Hashimoto, T Ishihara, ... Acute Medicine & Surgery 8 (1), e706, 2021 | 16 | 2021 |
| Japanese Rapid/Living recommendations on drug management for COVID‐19 K Yamakawa, R Yamamoto, G Ishimaru, H Hashimoto, T Terayama, ... Acute Medicine & Surgery 8 (1), e664, 2021 | 15 | 2021 |
| Rac1 in podocytes promotes glomerular repair and limits the formation of sclerosis R Asao, T Seki, M Takagi, H Yamada, F Kodama, Y Hosoe-Nagai, ... Scientific reports 8 (1), 5061, 2018 | 14 | 2018 |
| Impairment of proteasome function in podocytes leads to CKD S Makino, N Shirata, JAO Trejo, K Yamamoto-Nonaka, H Yamada, ... Journal of the American Society of Nephrology 32 (3), 597-613, 2021 | 13 | 2021 |
| Japanese rapid/living recommendations on drug management for COVID‐19: updated guidelines (July 2022) K Yamakawa, R Yamamoto, T Terayama, H Hashimoto, T Ishihara, ... Acute Medicine & Surgery 9 (1), e789, 2022 | 8 | 2022 |
| Chapter 1: Evaluation of kidney function in patients undergoing anticancer drug therapy, from clinical practice guidelines for the management of kidney injury during anticancer … S Muto, T Matsubara, T Inoue, H Kitamura, K Yamamoto, T Ishii, ... International Journal of Clinical Oncology 28 (10), 1259-1297, 2023 | 7 | 2023 |
| Blood purification could tackle COVID-19? H Yamada, S Ohtsuru Journal of Intensive Care 9, 1-4, 2021 | 6 | 2021 |
| Suppressor of cytokine signalling 3 (SOCS3) expressed in podocytes attenuates glomerulonephritis and suppresses autoantibody production in an imiquimod-induced lupus model M Fukuta, K Suzuki, S Kojima, Y Yabe, K Suzuki, K Iida, H Yamada, ... Lupus Science & Medicine 8 (1), e000426, 2021 | 4 | 2021 |
| Nephrotoxicity associated with anticancer agents: perspective on onconephrology from nephrologists T Matsubara, H Yokoi, H Yamada, M Yanagita International Journal of Clinical Oncology 28 (5), 625-636, 2023 | 2 | 2023 |
| Global perspectives in acute kidney injury: Japan H Yamada, M Yanagita Kidney360 3 (6), 1099-1104, 2022 | 2 | 2022 |
| Initial central venous pressure could be a prognostic marker for hemodynamic improvement of polymyxin B direct hemoperfusion: a retrospective cohort study H Yamada, T Tsukamoto, H Narumiya, K Oda, S Higaki, R Iizuka, ... Journal of Intensive Care 4, 1-8, 2016 | 2 | 2016 |
| Matrix metalloproteinase-10 deficiency has protective effects against peritoneal inflammation and fibrosis via transcription factor NFκΒ pathway inhibition T Ishimura, A Ishii, H Yamada, K Osaki, N Toda, KP Mori, S Ohno, Y Kato, ... Kidney International 104 (5), 929-942, 2023 | 1 | 2023 |
